Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery [Phase 2]
A Phase 2 trial evaluated panitumumab in combination with chemotherapy and external-beam radiation therapy for locally advanced pancreatic c…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors [NA]
The clinical trial update notes completion of a cognitive-behavioral intervention designed to help cancer survivors manage worry, uncertaint…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating a combination of gemcitabine, bevacizumab, and erlotinib in pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating high-dose vitamin C for advanced pancreatic cancer was terminated, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer [Phase 3]
Phase 3 trial completed evaluating nadroparin in patients with lung, pancreatic, or prostate cancer, focusing on venous thrombosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial of gemcitabine hydrochloride in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: TMS for the Treatment of Pancreatic Cancer Pain [NA]
This entry reports the completion of a clinical trial evaluating transcranial magnetic stimulation (TMS) for managing pain in pancreatic can…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients [Phase 1, Phase 2]
Phase I/II open-label dose-escalation trial of CPI-613 (devimistat) with gemcitabine in cancer patients; the study is terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study evaluating chemoradiation with gemcitabine in combination with panitumu…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine and erlotinib in metastatic or recurrent pancreatic cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer [Phase 2]
Phase 2 trial evaluating lapatinib plus capecitabine as second-line treatment for pancreatic cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial evaluating IPI-926 in combination with gemcitabine for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer
This completed pilot trial evaluated inter- and intra-treatment organ motion in pancreatic cancer patients using an Active Breathing Control…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 study evaluating the combination of pertuzumab and erlotinib for refractory pancreatic cancer was terminated, with results posted …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Exercise Intervention Study for Pancreatic Cancer Patients [NA]
A completed clinical trial assessing an exercise intervention for patients with pancreatic cancer, sponsored by the German Cancer Research C…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Gem-TABS in Unresectable Pancreatic Carcinoma [Phase 1]
This document reports a completed Phase 1 trial of Gem-TABS for unresectable pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients [Phase 2]
This ClinicalTrials.gov update reports on a phase 2 trial evaluating simvastatin with gemcitabine in pancreatic cancer that has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Comparing Methods to Biopsy Pancreas Mass [NA]
This completed clinical trial compared methods for biopsy of a pancreatic mass to determine the most effective diagnostic approach.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Study of Gemcitabine and Abraxane for Pancreas Cancer [Phase 2]
Georgetown University–sponsored Phase 2 trial evaluating gemcitabine in combination with Abraxane for pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A completed Phase I/II trial evaluating substituting nab-paclitaxel for either irinotecan or oxaliplatin in the FOLFIRINOX regimen as first-…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer [Phase 2]
This Phase 2 trial update reports the termination of a study evaluating palonosetron hydrochloride for preventing radiation-induced nausea a…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluates nab-paclitaxel (ABI-007) in combination with gemcitabine or with split-dose leucovorin and 5-fluorouracil (sLV5FU2…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Perception Prognosis, Goals of Treatment, and Communication
A completed clinical trial update from Massachusetts General Hospital examining prognosis, goals of treatment, and communication in gastric …
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer [Phase 1]
Phase I trial evaluating TS-1 with concurrent radiotherapy for metastatic pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study evaluating a pancreatic core biopsy needle in patients suspected of pan…